Skip to main content

Idexx Laboratories(IDXX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low552.00
Day High567.94
Open:556.92
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Bank of America Securities Reaffirms Their Hold Rating on Idexx Laboratories (IDXX)
Tipranks
Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and Idexx Laboratories (IDXX)
Zacks Investment Research
Top Stock Reports for Roche, AT&T & Amgen
Top Stock Reports for Roche, AT&T & Amgen
Tipranks
Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Idexx Laboratories (IDXX)
The Globe and Mail
13 U.S. health care stocks to consider in uncertain markets
For Number Cruncher column in Globe Investor/ROB only.
Motley Fool
Bamco Expands FactSet Stake to $838 Million as Financial Data Platform Drives Recurring Revenue
Zacks Investment Research
IDEXX Laboratories Stock Climbs 39.4% in a Year: What's Driving It?
IDEXX Laboratories Stock Climbs 39.4% in a Year: What's Driving It?
Tipranks
Analysts Conflicted on These Healthcare Names: Xenon (XENE), Idexx Laboratories (IDXX) and Warby Parker (WRBY)
Tipranks
Analysts Conflicted on These Healthcare Names: Akebia Therapeutics (AKBA), Idexx Laboratories (IDXX) and Arvinas Holding Company (ARVN)
Tipranks
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
Motley Fool
Vail Resorts Heads Into Ski Season Backed by Strong Epic Pass Sales
Motley Fool
Investment Manager Bets Big on Varonis Stock, According to Recent SEC Filing
Motley Fool
Got $5,000? Here's the Ultimate Pick-and-Shovel Pet Stock (Spoiler: It's Not Chewy)
Motley Fool
American Capital Management Doubles Down on Novanta Stock, According to Latest SEC Filing
Motley Fool
Investment Manager Bets on Proto Labs Stock, According to Recent SEC Filing
Tipranks
Analysts Conflicted on These Healthcare Names: Idexx Laboratories (IDXX), Arrowhead Pharmaceuticals (ARWR) and Disc Medicine (IRON)
Tipranks
Idexx Laboratories Announces Director Retirement and Board Changes
Tipranks
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Qiagen (QGEN) and InnovAge Holding (INNV)
Zacks Investment Research
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Tipranks
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST)
Tipranks
Idexx Laboratories Earnings Call Highlights Resilient Growth
Zacks Investment Research
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
Tipranks
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY)
Zacks Investment Research
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise
Motley Fool
IDEXX (IDXX) Q4 2025 Earnings Call Transcript
Tipranks
Bank of America Securities Reaffirms Their Hold Rating on Idexx Laboratories (IDXX)
Zacks Investment Research
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
MoneyShow
MoneyShow Top Picks 2026: Idexx Laboratories Inc. (IDXX)
Idexx Laboratories, Inc_ outside lab-by Sundry Photography via iStock
Zacks Investment Research
BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry
BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry
Zacks Investment Research
ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines
ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines
Tipranks
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Karyopharm Therapeutics (KPTI) and Simulations Plus (SLP)
Zacks Investment Research
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Profile

IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.